IMCD N.V. (“IMCD”), a leading distributor of speciality chemicals and ingredients, has entered into a share purchase agreement on 26 November 2020 to acquire the personal care business of Ejder Kimya İlaç Danışmanlık Sanayi ve Ticaret A.Ş (“Ejder Kimya”). The transaction is expected to close in January 2021, subject to customary closing conditions and regulatory approval.
Paksoy is pleased to announce that a team led by Elvan Aziz (partner) together with Gözde Zorlu (associate) and Simge Şengün (associate) acted as Turkish counsel to IMCD on this transaction.
Share
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
16 February 2026
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage.
12 February 2026
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey.
19 January 2026
Paksoy advises Amphenol on its acquisition of CommScope’s CCS business
Paksoy advises Amphenol Corporation on its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business.
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
13 January 2026
Paksoy advised IFC on its investment in Getmobil
Paksoy advised IFC on its investment in Getmobil.
12 January 2026
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025, advising on USD 4.97 billion across 18 transactions.
